{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "11113028",
  "DateCompleted": {
    "Year": "2001",
    "Month": "01",
    "Day": "04"
  },
  "DateRevised": {
    "Year": "2005",
    "Month": "11",
    "Day": "16"
  },
  "Article": {
    "ArticleDate": [],
    "Language": [
      "eng"
    ],
    "ELocationID": [],
    "Journal": {
      "ISSN": "1058-4838",
      "JournalIssue": {
        "Volume": "31 Suppl 5",
        "PubDate": {
          "Year": "2000",
          "Month": "Oct"
        }
      },
      "Title": "Clinical infectious diseases : an official publication of the Infectious Diseases Society of America",
      "ISOAbbreviation": "Clin Infect Dis"
    },
    "ArticleTitle": "Diagnostic implications and clinical consequences of antipyretic therapy.",
    "Pagination": {
      "StartPage": "S230",
      "EndPage": "S233",
      "MedlinePgn": "S230-3"
    },
    "Abstract": {
      "AbstractText": [
        "It has been suggested that the response to antipyretic therapy might differentiate between fevers due to serious illness and fevers caused by less severe disorders; that neoplastic fevers are more responsive to nonsteroidal anti-inflammatory drugs than are infectious fevers; that the metabolic costs of fever can exceeds its clinical benefits; that antipyretic therapy can prevent or reverse febrile seizures in children and fever-associated mental dysfunction in frail elderly patients. This article examines the data on which these assertions are based."
      ]
    },
    "AuthorList": [
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Medical Care Clinical Center, VA Maryland Health Care System and Department of Medicine, University of Maryland School of Medicine, Baltimore, MD 21201, USA. Philip.Mackowiak@med.va.gov"
          }
        ],
        "LastName": "Mackowiak",
        "ForeName": "P A",
        "Initials": "PA"
      }
    ],
    "PublicationTypeList": [
      "Journal Article",
      "Review"
    ]
  },
  "MedlineJournalInfo": {
    "Country": "United States",
    "MedlineTA": "Clin Infect Dis",
    "NlmUniqueID": "9203213",
    "ISSNLinking": "1058-4838"
  },
  "ChemicalList": [
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Analgesics, Non-Narcotic"
    }
  ],
  "MeshHeadingList": [
    {
      "QualifierName": [],
      "DescriptorName": "Adolescent"
    },
    {
      "QualifierName": [
        "adverse effects",
        "therapeutic use"
      ],
      "DescriptorName": "Analgesics, Non-Narcotic"
    },
    {
      "QualifierName": [
        "complications"
      ],
      "DescriptorName": "Bacterial Infections"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Child"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Child, Preschool"
    },
    {
      "QualifierName": [
        "drug therapy",
        "etiology"
      ],
      "DescriptorName": "Fever"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [
        "complications"
      ],
      "DescriptorName": "Neoplasms"
    },
    {
      "QualifierName": [
        "chemically induced",
        "prevention & control"
      ],
      "DescriptorName": "Seizures, Febrile"
    }
  ],
  "NumberOfReferences": "36"
}